1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Metabolic Autonomy of Cytotoxic Programs Distinguishes Responder from Non-Responder CAR-T Effectors in DLBCL: A Single-Cell Co-Expression Network Analysis

ABCL - 914

Metabolic Autonomy of Cytotoxic Programs Distinguishes Responder from Non-Responder CAR-T Effectors in DLBCL: A Single-Cell Co-Expression Network Analysis

Ali Turunc

Poster Presenter: Ali Turunc

$Thumbnail for Mezigdomide, Carfilzomib, and Dexamethasone (MeziKd) vs Carfilzomib and Dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma (RRMM): Results From the Phase 3 SUCCESSOR-2 Trial$

MM - 569

Mezigdomide, Carfilzomib, and Dexamethasone (MeziKd) vs Carfilzomib and Dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma (RRMM): Results From the Phase 3 SUCCESSOR-2 Trial

Meletios A Dimopoulos

Poster Presenter: Meletios A Dimopoulos

SOHO 2026 Annual Meeting

Posters by Title

Metabolic Autonomy of Cytotoxic Programs Distinguishes Responder from Non-Responder CAR-T Effectors in DLBCL: A Single-Cell Co-Expression Network Analysis

Mezigdomide, Carfilzomib, and Dexamethasone (MeziKd) vs Carfilzomib and Dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma (RRMM): Results From the Phase 3 SUCCESSOR-2 Trial

Micro-Costing Analysis of Adverse Events of Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Therapy in the United States

Micro-Dosed Obinutuzumab: A Novel Debulking Strategy in a Rare Case of Leukostasis From Chronic Lymphocytic Leukemia

Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma: From Surrogate Endpoint Validation to the Unanswered Question of Maintenance-Free Remission

Modulation of the Hepcidin Pathway Produces Homogeneous Erythropoietic Suppression but Heterogeneous Iron Repletion in Polycythemia Vera: Lessons from REVIVE and IMPRSSION.

Molecular and Pathologic Staging Gaps in Mycosis Fungoides and Sιzary Syndrome: Real-World Evidence From the LEO-MER Prospective Cohort

Molecular Predictors of Response to Venetoclax-Based Therapy in Acute Myeloid Leukemia

Molecular Profiling of Chronic Lymphoproliferative Diseases in Brazilian Patients: A Real-World Next-Generation Sequencing Panel Experience